baber/WOPTO huggingface dataset:
Patent AU-2020211073-A1 (AU)
Title: Food storage system, method and computer readable medium
Inventor: YOUNG CHRISTOPHER CHARLES
IPC: G06K19/06
Filed: 2020-01-24
Abstract: Systems and methods for sharing data about the contents of storage bags or containers with external devices are described herein. In several embodiments, a food storage system can operate to track/record data about the contents in multiple storage bags and to allow for the identification of the contents in the storage bags based on a unique identifier associated with the storage bags. In some embodiments, the food storage system can provide reminders, recommendations, or other prompts regarding the contents in the storage bags.
Patent AU-2020211431-A1 (AU)
Title: Ventricular assist device
Inventor: TUVAL YOSI
IPC: A61M60/13
Filed: 2020-01-23
Abstract: Apparatus and methods are described including a left-ventricular assist device (20) that includes a tube (24) configured to traverse a subject's aortic valve, with a distal portion of the tube disposed within the subject's left ventricle. A frame (34) is disposed within the distal portion of the tube. A pump (50) disposed within the frame pumps blood through the tube. A distal-tip element (107) defines a straight proximal portion (346) that defines a longitudinal axis (348), and a curved distal portion that is shaped such as to curve in a first direction with respect to the longitudinal axis before passing through an inflection point and curving in a second direction with respect to the longitudinal axis (348), such that the curved distal portion defines a bulge (351) on one side of the longitudinal axis (348). Other applications are also described.
Patent AU-2020217336-A1 (AU)
Title: Chiral diaryl macrocycles as modulators of protein kinases
Inventor: CUI JINGRONG J
IPC: C07D471/22
Filed: 2020-08-11
Abstract: CHIRAL DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES 
Abstract 
The present disclosure relates to certain chiral diaryl macrocyclic derivatives, 
pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, 
neurological diseases, autoimmune diseases, and inflammation.  
AH26(25623912 1):RTK
Patent AU-2020223683-A1 (AU)
Title: System and method for material conveyor container wear monitoring
Inventor: DENNIS PAUL M
IPC: G06K19/07
Filed: 2020-08-26
Abstract: A system and method for material conveyor bucket wear monitoring. A material 
conveyor system elevator bucket comprising a back wall, opposed sidewalls, a bottom 
wall curving upward into a front wall spaced from the back wall, a lip, a volume of space, 
and at least one wear monitor affixed to the elevator bucket, wherein the wear monitor 
transmits information using electromagnetic fields.
1/6 
FIG. 1 26 
10 
36 
18 
37 22 
33 
34 
14 
24 
12 34 
36 
22 16 
32 20 26
Patent AU-2020230210-A1 (AU)
Title: Automated simultaneous process control
Inventor: SCHWAN PETER
IPC: G05B11/06
Filed: 2020-02-19
Abstract: Described herein is a method and a system for automated simultaneous control of at least two process characteristics of a continuous production process with at least one fluid stream, at least two unit operations, at least one process control system and at least one conditioning volume.
Patent AU-2020245346-A1 (AU)
Title: Reducing intersample analyte variability in complex biological matrices
Inventor: DROLET DANIEL
IPC: G01N33/50
Filed: 2020-03-20
Abstract: Described herein are compositions and methods for reducing the variability of inter-sample analyte measurements from a biological matrix. In some embodiments, the present disclosure relates to methods for reducing the variability in the inter-sample levels of one or more proteins from a biological sample as measured by a proteomic assay.
Patent AU-2020267037-A1 (AU)
Title: Gelling leguminous protein
Inventor: LAROCHE CHRISTOPHE
IPC: A23J3/14
Filed: 2020-04-29
Abstract: The invention relates to a leguminous protein composition having an improved gel strength at neutral pH and to a method for the production thereof.
Patent AU-2020269901-A1 (AU)
Title: Vasoactive intestinal peptide (VIP) for use in the treatment of drug-induced pneumonitis
Inventor: MÜLLER-QUERNHEIM JOACHIM
IPC: A61P11/00
Filed: 2020-05-05
Abstract: Checkpoint inhibitor-induced pneumonitis (CIP) is characterized clinically by dyspnea, cough and tachypnea. Hypoxia results from a lymphocyte-dominated alveolitis leading to ground glass opacities and consolidations observed by CT scan. Histological findings include lymphocytic infiltrates, granuloma formation and eosinophilic accumulation. In the management of CIP, systemic administration of steroids such as methylprednisolone is the standard therapy. Moreover, CIP in most cases leads to discontinuation of checkpoint inhibitory therapy and steroids limit the therapeutic effect of checkpoint inhibitors resulting in progression of the underlying malignant disease. Therefore, there is a need of other therapeutic options in CIP that ideally could abrogate the alveolar inflammation induced by checkpoint inhibitors without affecting the systemic effect on the immune system. The focus of the present invention is to deliver a solution to that problem by the topic application of VIP (vasoactive intestinal peptide, a peptide of 28 amino acids). A drug for inhalative VIP therapy is commercially available under the name Aviptadil.
Patent AU-2020280860-A1 (AU)
Title: Anti-influenza virus composition, composition for treating respiratory diseases, and anti-aging composition, comprising dark ginseng extract
Inventor: SOUNG DO YU
IPC: A61K36/258
Filed: 2020-05-20
Abstract: The present invention relates to an anti-influenza virus composition, a composition for treating respiratory diseases, and an anti-aging composition, each of which comprises a dark ginseng extract.
Patent AU-2020286251-A1 (AU)
Title: Dual PDGF/VEGF antagonists
Inventor: PERLROTH D VICTOR
IPC: C07K16/22
Filed: 2020-12-09
Abstract: The invention provides a dual VEGF/PDGF antagonist comprising a VEGF 
antagonist linked to a PDGF antagonist. The VEGF antagonist is an antibody to a VEGF or 
VEGFR or is a VEGFR extracellular trap segment (i.e., a segment from the extracellular 
region of one or more VEGFR receptors that inhibits binding of at least one VEGFR to at 
least one VEGF). The PDGF antagonist is an antibody to a PDGF or PDGFR or is a PDGFR 
extracellular trap segment (i.e., segment from the extracellular region of one or more 
PDGFRs, which inhibits binding of at least one PDGFR and at least one PDGF). The dual 
antagonist is preferably conjugated to a half-life extending moiety, such as a HEMA-PC 
polymer. The dual antagonist is particularly useful for treating wet aged related macular 
degeneration.
Patent AU-2020287079-A1 (AU)
Title: Thermogelling cannabinoid composition and method of manufacture and use thereof
Inventor: SAVARD JAMIE
IPC: A61K47/14
Filed: 2020-06-05
Abstract: The present disclosure relates to a cannabinoid composition that has enhanced absorption rates or higher concentrations of the administered cannabinoid into the systemic circulation, the composition comprising at least one cannabinoid and a viscosity modifier present in an effective amount to change the composition from a liquid at about room temperature to a gel upon increase to about body temperature. The disclosure also relates to methods of use of the compositions and cannabinoid products comprising such compositions.
Patent AU-2020322459-A1 (AU)
Title: Dressing for providing low oxygen environment
Inventor: LASH THOMAS E
IPC: A61L15/42
Filed: 2020-07-29
Abstract: A dressing includes an application site covering and an oxygen scavenger provided with or positioned with respect to the application site covering so as to remove oxygen from a volume beneath the application site covering and around an application site covered by the application site covering. The application site covering and the oxygen scavenger are configured to maintain gas pressure beneath the application site covering around the application site that is above a therapeutic negative pressure while the oxygen scavenger is consuming oxygen beneath the application site covering.
Patent AU-2020330701-A1 (AU)
Title: Method for determining process variables in cell cultivation processes
Inventor: ERHARD KRISTINA
IPC: G05B13/04
Filed: 2020-08-12
Abstract: High throughput cultivation systems are used in pharmaceutical research and development. In this connection, samples are taken and analyzed for important parameters using external analysis. The results of the analysis serve to assess the cultivation process and provide important information about the process. Especially with cultivations carried out in parallel, the manual effort of sample preparation is great and can lead to errors. In order to avoid the need for sampling and thus to minimize the errors, a method is described in the present patent application which makes desired target parameters accessible in the form of soft sensors by means of previously recorded process variables. Herein is described a method for determining process-relevant parameters in CHO processes (Chinese hamster ovary) in high- throughput cultivations, in particular glucose, lactate and the live cell density or the live cell volume.
Patent AU-2020392166-A1 (AU)
Title: Pharmaceutical composition for treatment of cancer, comprising immune checkpoint inhibitor and fusion protein including IL-2 protein and CD80 protein
Inventor: JANG MYOUNG HO
IPC: A61K38/20
Filed: 2020-11-27
Abstract: The present invention provides a pharmaceutical composition for treatment of cancer, comprising, as active ingredients, a fusion protein dimer including IL-2 protein or a variant thereof and CD80 protein or a fragment thereof and an immune checkpoint inhibitor. A fusion protein comprising CD80 fragment, immunoglobulin Fc, and an IL-2 variant according to an embodiment of the present invention can activate immune cells such as natural killer cells while controlling the immune cell regulation activity of regulatory T cells. In addition, the administration of an immune checkpoint inhibitor known as an PD-1 inhibitor, such as keytruda, in combination with the fusion protein can effectively inhibit cancer. Therefore, a pharmaceutical composition comprising, as active ingredients, a fusion protein including IL-2 protein or a variant thereof and CD80 protein or a fragment thereof and an immune checkpoint inhibitor can be effectively utilized for the treatment of cancer and thus is of high industrial applicability.
Patent AU-2020397923-A1 (AU)
Title: Folded total protection garment
Inventor: MITHANI NAMITA A
IPC: A41H43/02
Filed: 2020-12-04
Abstract: A folded article formed from a protective garment (101), and a method of folding a protective garment to prepare the garment for donning, expose sleeve (104, 105) openings of the garment for ease of donning. The protective garment is folded into a folded article that is configured to be grasped by an inner surface of the garment and prevent touching the outer surface of the garment during donning. Thus, the sterility of the protective garment can be maintained during donning. The protective garment may further include a hood (178) and visor (180), and the folded article formed from the protective garment may have the same size and shape as the visor.
Patent AU-2020399153-A1 (AU)
Title: Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary alkyl ammonium compounds
Inventor: LEINWEBER DIRK
IPC: C10L3/10
Filed: 2020-12-04
Abstract: The present disclosure relates to a gas hydrate inhibitor composition comprising from an amphiphile having a hydrophobic tail linked to a hydrophilic head group by a linking moiety, the amphiphile having the general formula (1) [R
Patent AU-2021204792-A1 (AU)
Title: Pressure relief system for footwear
Inventor: O'REILLY BRIAN
IPC: A61F5/00
Filed: 2021-07-08
Abstract: PRESSURE RELIEF SYSTEM FOR FOOTWEAR 
ABSTRACT OF THE DISCLOSURE 
Systems and methods are described for a shoe sole for relieving pressure from a 
wearer's metatarsal heads. A shoe sole may include a shoe outer sole having a shaft region, 
a ball region, and a toe region. The shaft region underlies metatarsal shafts of the wearer and 
comprises a first lower surface, the ball region underlies metatarsal heads of the wearer and 
comprises a second lower surface, and the toe region underlies phalanges of the wearer and 
comprises a third lower surface. The second lower surface may be raised relative to the first 
lower surface and the third lower surface.
Patent AU-2021223289-A1 (AU)
Title: A method for operating a photovoltaic system
Inventor: KAMPL TOBIAS
IPC: H02S50/00
Filed: 2021-02-03
Abstract: A photovoltaic system comprising an inverter adapted to convert a DC power supplied by photovoltaic modules of a photovoltaic generator via power cables to said inverter into an AC current for an AC power supply grid, wherein the inverter has a base station connected by means of the power cables to the module level devices which are provided to monitor and/or to control associated photovoltaic modules of the photovoltaic generator, wherein if the inverter does not receive sufficient energy from the photovoltaic generator and the AC power supply grid, a controller is adapted to activate a deadlock prevention mode of an energy supply unit connected to the inverter where the inverter receives energy from the energy supply unit such that the base station of the inverter is able to continue to transmit permission to operate, PTO, signals via the power cables to the module level devices of the photovoltaic generator.
Patent AU-2021224740-A1 (AU)
Title: Expanded ball seat
Inventor: O'BRIEN ROBERT
IPC: E21B33/128
Filed: 2021-02-19
Abstract: A method of installing a ball seat in a wellbore, comprising conveying the ball seat via a support member of a tool to a target location in the wellbore; moving an expansion sleeve longitudinally with respect to the tool to expand the ball seat radially to engage the ball seat to a support structure of the wellbore at the target location; and releasing the support member from the engaged ball seat.
Patent AU-2021245183-A1 (AU)
Title: Process and plant for producing co-rich synthesis gas by partial oxidation
Inventor: MUELLER-HAGEDORN MATTHIAS
IPC: C01B3/22
Filed: 2021-10-07
Abstract: : 
Proposed are a process and a plant for producing a hydrogen- and carbon oxides
containing synthesis gas by partial noncatalytic oxidation of a fluid or fluidizable carbon
containing input stream of fossil origin as a first input stream in the presence of an 
oxygen-containing oxidant and optionally a moderator to obtain a CO-rich raw synthesis 
gas. According to the invention a second input stream comprising a pyrolysis oil 
obtained from biomass is reacted simultaneously with the first input stream in the 
noncatalytic partial oxidation.
2 5 49 
50 
11I 
3 
410 
12 21 22 4 
20 23 
32 44 
30 40 
24 46 
42 
Fig. 2 
13 14
Patent AU-2021258048-A1 (AU)
Title: Device for detecting insect larvae and adult insects in stored products by sensing their volatile pheromones and semiochemicals
Inventor: SMILANICH NICHOLAS JOSEPH
IPC: A01M99/00
Filed: 2021-10-28
Abstract: : 
Portable devices are used to detect the presence of insect larvae and adult insects 
in stored products by sensing gas phase markers such as volatile pheromones, 
semiochemicals, and kairomones. The methods, devices, and systems disclosed 
herein utilize a sensor array configured to simultaneously measure a plurality of 
target markers and filter background gases while remaining compact, highly 
accurate, and easy to operate. The sensor array may include a plurality of VOC 
sensors and the method may include heating at least one VOC sensor.  
[FIG. 7]
8/24 
C 
C 
<L
01 
00LL 
Nr.  
oc 
co w 0 
Co CD10- to 
W Z a 0 0 
o o -o C 
00 
o LL0 
P- -o D 
cc~ 
I- W Z 
C0 0 
w r 
coo ID 
o o 
ND N NN N N 
z z co 
U) co co 
Qo o 0 
z > > > 
w 
ICO
Patent AU-2021260682-A1 (AU)
Title: Gonadotropin releasing hormone receptor antagonist and use thereof
Inventor: LIU GUOQIANG
IPC: A61P5/02
Filed: 2021-05-20
Abstract: Provided is a compound or a pharmaceutically acceptable salt, isomer, prodrug, polymorph, or solvate thereof, and a preparation method therefor and use thereof. The compound is used as a GnRHR antagonist in a calcium flux detection experiment, has an activity equivalent to or better than that of Elagolix, and has better pharmacokinetic properties.
Patent AU-2021263809-A1 (AU)
Title: Cannula insertion system and methods of using the same
Inventor: FLAKE ALAN W
IPC: A61M25/06
Filed: 2021-04-28
Abstract: A cannula insertion system for cannulating a blood vessel includes a cannula system having a cannula that defines a cannula lumen and has a distal and proximal end. The system includes a cannula insertion device for coupling with the system that includes a dilator having a dilator body and a dilator lumen; a needle having a needle body and a needle lumen, the needle being translatable within the dilator lumen along a first direction; a movable dilator actuator configured to cause the dilator to move along the first direction; a movable needle actuator configured to cause movement of the needle along the first direction; and a housing defining a housing recess. The housing recess is configured to receive the cannula system, the dilator, and the needle. The needle and the dilator are configured to be moved within the cannula lumen along the first direction.
Patent AU-2021269187-A1 (AU)
Title: Device and method for unattended treatment of a patient
Inventor: SCHWARZ TOMÁS
IPC: A61B18/20
Filed: 2021-05-03
Abstract: An unattended approach can increase the reproducibility and safety of the treatment as the chance of over/under treating of a certain area is significantly decreased. On the other hand, unattended treatment of uneven or rugged areas can be challenging in terms of maintaining proper distance or contact with the treated tissue, mostly on areas which tend to differ from patient to patient (e.g. facial area). Delivering energy via a system of active elements embedded in a flexible pad adhesively attached to the skin offers a possible solution. The unattended approach may include delivery of multiple energies to enhance a visual appearance.
Patent AU-2021271612-A1 (AU)
Title: Pharmaceutical composition for use in treating subject in hypoxic state due to respiratory failure, etc.
Inventor: TAKEBE TAKANORI
IPC: A61M31/00
Filed: 2021-05-13
Abstract: The present invention provides a pharmaceutical composition containing oxygen-dissolved perfluorocarbon, for use in administering oxygen to a subject. The present invention also provides a perfluorocarbon-containing pharmaceutical composition, for use in reducing the partial pressure of carbon dioxide in blood.
Patent AU-2021275217-A1 (AU)
Title: Rapidly insertable central catheters including catheter assemblies
Inventor: HOWELL GLADE H
IPC: A61M25/09
Filed: 2021-05-20
Abstract: Rapidly insertable central catheters ("RICCs") including catheter assemblies are disclosed. For example, a RICC assembly includes a RICC (102) and an introducer (104). The RICC includes a catheter tube (106), a catheter hub (108), and one or more extension legs (110) coupled in the foregoing order. The catheter tube includes a side aperture (114) that opens into an introducing lumen that extends from at least the side aperture to a distal end of the RICC. The introducer includes a retractable-needle device (140), a syringe (142), and a coupling hub (144) that couples the retractable-needle device and the syringe together proximal of the side aperture in a ready-to-deploy state of the RICC assembly. The retractable-needle device includes an introducer needle (146). A needle tip in a distal- end portion of a shaft of the introducer needle extends beyond the distal end of the RICC when the RICC assembly is in the ready-to- deploy state of the RICC assembly.
Patent AU-2021316655-A1 (AU)
Title: Medical container, such as a pre-fillable or prefilled syringe, comprising a RFID tag for remote identification of said medical container
Inventor: RIVIER CÉDRIC
IPC: A61M5/158
Filed: 2021-07-26
Abstract: Medical container and method for manufacturing said medical container This medical container (1) comprises a barrel defining a reservoir for containing a medical product, and a needle (4) extending in a barrel channel (24) provided at a distal end (20) of the barrel so as to establish a fluid communication between the reservoir and the needle (4). The medical container (1) further comprises a RFID on-metal (ROM) tag (8), said RFID on-metal (ROM) tag (8) being located at least partly inside the barrel channel (24) and having an antenna (82) extending along the needle (4).
Patent AU-2021325073-A1 (AU)
Title: Systems and methods for private authentication with helper networks
Inventor: STREIT SCOTT EDWARD
IPC: G06N20/00
Filed: 2021-08-12
Abstract: Helper neural network can play a role in augmenting authentication services that are based on neural network architectures. For example, helper networks are configured to operate as a gateway on identification information used to identify users, enroll users, and/or construct authentication models (e.g., embedding and/or prediction networks). Assuming, that both good and bad identification information samples are taken as part of identification information capture, the helper networks operate to filter out bad identification information prior to training, which prevents, for example, identification information that is valid but poorly captured from impacting identification, training, and/or prediction using various neural networks. Additionally, helper networks can also identify and prevent presentation attacks or submission of spoofed identification information as part of processing and/or validation.
Patent AU-2021341537-A1 (AU)
Title: Multi-beam passively-switched patch antenna array
Inventor: GAMALSKI ANDREW D
IPC: H01Q25/00
Filed: 2021-02-04
Abstract: An apparatus includes multiple patch antenna elements (202) configured to transmit multiple electromagnetic beams (106a-106b) in multiple beam directions. The apparatus also includes multiple inputs each configured to receive one of multiple input signals (302a-302b), where each input signal is associated with one of the electromagnetic beams. The apparatus further includes multiple phase-tapered splitters (304a-304b) each configured to receive one of the input signals, divide the received input signal into a set of sub-signals, and provide a phase taper that adjusts phases of at least some of the sub-signals in the set of sub-signals. Different phase tapers are associated with different ones of the beam directions. In addition, the apparatus includes multiple 90° hybrid transformers (308) each configured to receive sub-signals associated with different ones of the input signals, isolate the received sub-signals from each other, and provide the isolated sub-signals to one of the patch antenna elements.
Patent AU-2021345545-A1 (AU)
Title: Device for heating and frothing milk
Inventor: MOLINARO GABRIELE
IPC: A47J31/44
Filed: 2021-09-15
Abstract: A device for heating and frothing milk, comprising a steam generator (10) and a jet pump (31), the jet pump comprising a steam inlet (31a) through which pressurized steam is injectable into the jet pump (31), and a first suction inlet (31b) and a second suction inlet (31c), wherein the first suction inlet (31a) is configured to connect to a milk reservoir. An air inlet (41.3; 51) is connectable or connected to the second suction inlet (31c) of the jet pump (31) for drawing air into the jet pump (31). A bypass valve (41) is connected to the second suction inlet (31c) of the jet pump (31) and has a bypass inlet (41.2). The bypass valve is switchable between a first position in which the second suction inlet (31c) of the jet pump (31) is shut off from the steam generator (10), and a second position in which the second suction inlet (31c) is in fluid communication with the bypass inlet (41.2) of the bypass valve (41) for the suction of steam.